Author: admin

Jennifer Choo joins Menicon as Clinical Director of specialized lenses.

|

Jennifer Choo joins Menicon as Director clinic lenses specialized.

– Menicon will expand its presence in the market of custom contact lenses

Nagoya, Japan, August 23, 2011- / PRNewswire / – Menicon Company Ltd. announced the appointment of Dr. Jennifer Choo as Director of Clinical Affairs of lentesespecializadas on 23 August in Menicon Holdings B.V. Dr Choo will oversee business Rose K of the company while it manages the professional and Clinical Affairs for the growing portfolio of specialized lenses of the company.

During the past three years, Dr. Choo has been leader of project in Adventus Technology Inc. and Brien Holden Vision Institute (BHVI) headquartered in Sydney, Australia. Dr Choo has led and managed international and interdisciplinary teams in the development of ophthalmic products surgical innovators. She was previously Director of Orthokeratology Research in BHVI projects while completing his doctorate.

Dr Choo graduated in cell biology and genetics from the University of British Columbia in Vancouver. He obtained his doctorate in optometry by Pacific University College of Optometry in Portland, Oregon, and received his doctorate in science from the University of New South Wales in Sydney, Australia vision.

Dr Choo has a strong overall as a lecturer and educator experience and has also received several awards for research. has demonstrated outstanding leadership abilities while he oversees the development, production and evaluation of new ophthalmic devices. “Dr. Choo was recorded in Vancouver, Canada, and inform Jonathan Jacobson, CEO of Menicon Holdings B.V.

“”I am extremely excited to join the team of Menicon,” said Dr. Choo. “Menicon is a diverse, dynamic and multinational company that works continuously to improve and innovate within the markets of contact lenses and lens care.” “I am eager to work with the team and use my skills and experience to help expand and establish the presence of the company globally.”

Jacobson commented: “We are delighted to welcome Dr. Choo to Menicon”. “His considerable experience in clinical research and specialized lenses is invaluable to Menicon’s global expansion plans, particularly during an active period of new introductions of products”.

About Menicon

Menicon Co., Ltd. founded by Kyoichi Tanaka in 1951, is the first and largest manufacturer of Japan contact lenses, and already has representation in more than 30 countries. Menicon is a manufacturer dedicated to all areas of business related to soft lenses and of de contacto contact GP, including development of material, design of lenses and manufacturing of contact lenses and solutions of treatment. Menicon is a world leader in the development of lenses hyper-Dk GP (Menicon Z) and contact soft (Menicon prize).

Read More

Phadia AB extends its offer in the field of personalized medicine and tests to detect antibodies against drugs thanks to a partnership with Biomonitor A/S.

|

Phadia AB extends its offer in the field of personalized medicine and tests to detect antibodies against drugs thanks to a partnership with Biomonitor A/S.

“ Uppsala, Sweden and Copenhagen, Denmark, August 22, 2011- / PRNewswire / – Phadia AB and Biomonitor A/S today announced their collaboration in immunogenicity testing and monitoring of patients treated with medication biopharmaceuticals.

“”To join our portfolio BioMonitor iLite technology we become the most complete provider of solutions for antibody against drugs tests”, said Hans Johansson, director of Phadia business development. “Now we can offer services and products relating to the tests to detect antibodies against drugs in a spectrum, from preclinical research to the monitoring of patients in clinic for most of the clinically relevant tests of this kind”.

Immunogenicity and monitoring of patients

A growing concern in the development of medicines bioterapéuticos is the response of the immune system to each drug. Guidelines from the authorities require data on any immunological response and encourage early evidence of immunogenicity for all patients in development. In the case of medicinal products for clinical use, the monitoring of drugs bioterapéuticos constitutes a component of the personalization of medical treatment in a scheme that allows the regular testing of the patient to measure levels of bioactive of medicine and the possible formation of antibodies that Deplete the action of the drug. The patients are expensive, and when administered to treat chronic diseases, it is essential to monitor the reaction of the patient to optimize health care and control diseases associated with the disease.

Phadia AB, leader in diagnosis of Allergy and autoimmunity world for more than 40 years, recently adopted a strategy to commercialize their technologies for measurement of antibody in the field of the detection of antibodies against drugs.

The clinical laboratory of Phadia platform is used in more than 3,000 clinical analysis laboratories in the poses. The current platform can adapt easily to monitor the levels of antibodies to the drug in patients receiving treatment with medications biopharmaceuticals.

Work and investigations of Biomonitor have gained him a place among the world leaders in trials based on cells and the monitoring of patients with treatment of bioterapéuticos due to the use of proprietary tests and other drugs. In the past eight years Biomonitor has actively participated in the Danish multiple sclerosis group and monitored patients who suffer from this disease and are treated with interferon beta. In addition, the company has monitored neutralizing antibodies against the drug and drug levels in patients with rheumatoid arthritis and Crohn’s disease treated with alpha TNF antagonists.

Technology iLite (TM)

The Alliance is based on the technology iLite (TM) of Biomonitor. This patented technology combines a sophisticated methodology for testing of indicator gene cells Cryopreserved and inhibited Division can answer sensitive and reliably to report activity of the drug biotherapeutic in the serum of the patient and can measure levels of neutralizing antibodies. Cells Biomonitor (TM) iLite are manufactured and tested according to the strictest standards of quality (certification ISO 13485) and have been validated in various laboratories.

Dr. Arsalan Kharazmi, CEO of Biomonitor, commented: “we are pleased and excited with Phadia collaboration;” Thanks to her, Biomonitor can take advantage of our years of experience in cell-based analysis and the monitoring of patients, and employ our patented technology comprehensively iLite (TM) of indicator gene with the help of our extraordinary company of diagnosis. “We are convinced that the monitoring of drug bioterapéuticos will increase the efficacy of treatments, will result in savings for health care systems and improve the care provided to patients”.

Hans Johansson, Phadia business development director, said: “In this new and important market, our platform ImmunoCAP provides valuable clinical the clinical professional staff.” Technologies based on cells, such as iLite, are an essential component to accelerate developments in this field. “We are excited you about greatly add iLite technology to offer we provide clinics and pharmaceutical companies in order to improve the achievement of new patients”.

About Biomonitor

Biomonitor A/S is a Danish private company, founded in 2003 and funded by Sunstone Capital, Denmark. Among the leading companies in the development of innovative and reliable for testing technologies, and the incorporation of such analysis to complex and extensive programs of monitoring patients. In addition to the programs of monitoring for patients with multiple sclerosis, the company offers services of clinical analysis for patients in therapy anti-TNF (both levels of medication and detection of antibodies to the drug) and, as a contract research organization, supporting the pharmaceutical and biotechnology industries in their drug development programs for diverse classes of patients. Biomonitor Limited is a subsidiary wholly owned Biomonitor A/S, located in Galway, Ireland, and is a production plant with ISO certification.

About Phadia

Phadia AB develops, manufactures and sells complete systems for analysis of blood in support to clinicians diagnostic and monitoring of people with allergy, asthma and autoimmune conditions. Its mission is to significantly improve the management of allergy, asthma and autoimmune diseases by providing the health-care professionals superior technologies for diagnosis and clinical expertise. Phadia is provider of seven out of every ten laboratory tests to detect allergies in the world, and four of every ten tests of Autoimmunity in European laboratories.

Read More

Phadia launches Phadia 2500 and 5000 Phadia: a growing variety of solutions for diagnostics of allergies and autoimmune diseases.

|

Phadia launches Phadia 2500 and 5000 Phadia: a growing variety of solutions for diagnostics of allergies and diseases autoimmune.

-instruments of great capacity, that combine evidence of allergies and autoimmune diseases, and based on the proven technology of Phadia for reliability

Uppsala, Sweden, August 23, 2011- / PRNewswire / – today Phadia, global leader in diagnostics of allergies and autoimmune diseases, announced the launch of the new instruments of Phadia for allergies and autoimmune diseases tests: Phadia 2500 and 5000 Phadia.

The new instruments of great capacity offer the possibility of combining evidence of allergies and autoimmune diseases, which means one performance 4 to 5 times greater than that of any other instrument combined available to today. With 2500 Phadia, laboratories can offer up 25,000 results per week and up to 50,000 results using Phadia 5000. Both instruments are flexible, with the possibility of analyzing more than 600 allergens and 80 components allergenic, in combination with a panel of antigens for autoimmune diseases, optimized to evaluate more than 20 autoimmune diseases. For high productivity, better support and assistance for the resolution of problems, can connect instruments to Lab Community (community laboratory), which is the system of monitoring of Phadia remote insurance.

“Phadia 2500 and 5000 Phadia provide flexibility, high capacity and reliability”. “They are based on proven technology and are well equipped to satisfy large volumes of demand for clinical laboratories to waiting times shorter, higher performance and efficiency,” said Peter Silfwerbrand, Executive Vice President.

The new instruments of great capacity based on the same technology employed in the family of Phadia Laboratory Systems (Phadia laboratory systems) products, including Phadia 100, Phadia 250 and 1000 Phadia. Grouping and combining various instruments within the Phadia Laboratory Systems provides a number of exclusive advantages, that used the same software on all computers, including managing the results of the tests with Phadia Information Data Manager (Administrator Phadia data information), which is easy to use and intuitive, or evaluate the quality by means of the largest in the world of quality assessment program, Phadia Quality Club (Phadia quality Club), which is optional. In order to increase efficiency, the instruments can connect to a Laboratory Automation System (laboratory automation system) to handle and transport tubes of samples.

With the launch today, Phadia offers a full range of tools and components to diagnose allergies and autoimmune diseases; which meets the demands of clinical laboratories around the world, from the smallest to the largest.

About Phadia

Phadia develops, manufactures and markets blood test complete systems to support clinical diagnosis and controlling allergies, asthma and autoimmune diseases. Our mission is to substantially improve the management of allergy, asthma and autoimmune diseases, health professionals offering diagnostic technologies superiors and clinical expertise. We provide more than seven of ten laboratory tests to diagnose allergies around the world; and four of ten tests of autoimmune diseases to laboratories across Europe.

Read More

Otitis externa: caring for our ears in summer.

|

Otitis externa: caring for our ears in summer

-approximately 60% of the cases relate to children aged between 2 and 12 years, whose ear canal is narrower, producing them fever and inflammation of the skin surrounding the affected ear

-To this type of otitis is also known as “ swimmer’s ear ” and affects both children and adults

Torrevieja, 2011-August the service of Otolaryngology of the Hospital of Torrevieja, managed by Bank health and Asisa and integrated in the public network of the Generalitat Valencianainforms of the care and precautions to take with the arrival of the summer in relation to our ears, because they are frequent the otitis, or infections of the outer part of the ear.

Frequent baths in the sea and swimming pools and the humidity in the air are part of the factors that contribute to that small and older will be forced to go to your doctor to treat a strong ear pain very annoying for those who suffer. Approximately 60% of the cases relate to children aged between 2 and 12 years, whose ear canal is narrower, producing them fever and inflammation of the skin surrounding the affected ear.

Otitis externa is an inflammation of the ear which affects the ear canal, which is the tube that runs from the eardrum to the ear. This type of otitis is also known as “ swimmer’s ear ” and affects both children and adults. Among the factors that favour the development of external otitis are moisture, excessive cleaning of the ear, manipulation with rods or other instruments, injured in the duct, contact with chemical irritants such as hair sprays, dyes and skin problems of the channel as eczema or dermatitis. Patients with diabetes and other diseases, which produce a decrease in defences, are more likely to develop infections.

DRA

. Marta Arroyo, specialist in Otolaryngology and head of service of the Hospital in Torrevieja warns of the importance of prevention towards avoid this type of Pathology, therefore asserts that “ should avoid the manipulation of the ears with rods, without bathing in contaminated areasdo not make frequent handwashing with SOAP ears and keep them dry when necessary. Thus is can use ear plugs to the bathroom, either dry the ear after bathing with a towel or tilting the head to one side, and even using a hairdryer with mild air ”.

Otitis is produced by various germs that grow in the skin of the ear canal, causing inflammation with pain, a feeling of tamponade and deafness. According to the DRA. Arroyo “ another common symptom is the otorrhea, the drainage or output of fluid or pus in the ear; drainage can make that hearing is affected on a temporary basis. On the other hand, the sense of occupation of the ear, by inflammation of the duct can make it appear almost closed is also common ”.

treatment for this type of infections must have an analgesic component for the control of pain, and a topical antibiotic applied inside the ear in order to eradicate the infection. In some cases with topical drops with acetic acid or boric compounds will be sufficient, in other cases, your doctor will recommend compounds with antibiotic with or without steroids.

Experts recommend that, for at least one week, the patient must remain with the treatment prescribed by your doctor, avoiding the contact of the ears with water and thus ensuring that there is an optimal cure of the infection.

Prevention is the key

Prevention is the best measure to maintain healthy ear. Good conditions of dryness and handling in excess of the ear canal are indispensable for this. Hairdryer with no hot-applied air smoothly can be a useful tool for the drying of the ears, although there are also prepared with effect of drying that improve the PH of the skin by a compound in drops containing boricado alcohol.

It is important that, before any symptoms, go to your nearest health care center in order to obtain a rapid diagnosis to put an end to such problems through the appropriate treatment for each case.

Read More
“Actíva tea” after the holidays.

“Actíva tea” after the holidays.

|

“ Actíva – tea ” after the holidays.

“ Saboreatéycafé ”, the chain specialized in tasting and sale of tea and coffee, launches a drink for the return to routine.

-Infusion is made with tea green sencha, ginseng, licorice, lemon and natural aroma

Madrid, 2011-August with therapy or vitamins. Post-holiday depression happens with something as simple and healthy as a tea. And is that Saboreatéycafé the network of establishments specializing in the purchase and taste of teas (always with a designation of origin, traceability and labelling) has just launched “ Actíva-tea ”, a drink that helps us to charge batteries. “ Always heard that after our days of leisure we went through a period of depression until the return to normal. To make easier the known post-holiday depression in Saboretéycafé laboratories have devised Actíva-tea ”, says Mario Rubio de Miguel, President of the recognized string of restoration.

what is it about this original drink to activate both and as well? Very simple, “ ingredients of life with claims on our body and mind ”, adds the steering. These are the same:

-green tea sencha. It is toasted tea made Japan in which téina us active and gives us energy. Moreover is diuretic and depurative.

-Ginseng. The plant from the East of Liberia as well as the Northwest of China and Korea by its principles adaptogens or energetizantes activate our mind and fight fatigue.

-licorice. Its sweet base, which is none other which the glycyrrhizin helps prevent the drudgery of stomach as well as that we have to add sugar to the drink.

-lemon. in addition to vitamin C, this fruit has so few calories as low sodium. Why is perfect as an accompanist in slimming diets

-natural Aroma. To give the final touch of olfactory.

Add to each infusion “ active-tea ” costs 1,30 € and can only, or taste in all the establishments Saboretéycafé has spread by our country, or we can take her home or give to family, friends or co-workers in individual bags of 100 grams. The price in this case is 3.95 euros and is designed for 50 teas. Your order over the Internet can also make.

In the event that we go to Portugal also we can enjoy this delicious drink. Just have to go to any of the franchises that Saboretéycafé have spread the Portuguese country and ask for a “ active-Tea ”. do you dare to try it?.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips